Regenxbio Inc (RGNX) stock news · rev $170.4M
Regenxbio Inc (RGNX) is a biotechnology company listed on US.
This RGNX news page leads with what Regenxbio Inc filed — not a scraped headline mill.
No cached 8-K sentence for RGNX yet. We will not pad this page with generic market recap.
Latest reported RGNX revenue for 2025-12-31 was $170.4M. Net income was -$193.9M. Revenue was up 104.5% from 2024-12-31 to 2025-12-31. RGNX currently screens at market cap $440.4M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the RGNX stock page; for the tape open the quote page.
RGNX stock news FAQ
What are RGNX's latest revenue and net income?
Latest cached Regenxbio Inc (RGNX) revenue for Dec 31, 2025 was $170.4M. Net income was -$193.9M. Statements: https://lician.com/financials/rgnx
How did RGNX revenue change from the prior cached period?
Cached Regenxbio Inc (RGNX) revenue was up 104.5% from $83.3M (Dec 31, 2024) to $170.4M (Dec 31, 2025). Statements: https://lician.com/financials/rgnx
What is RGNX's market cap?
Regenxbio Inc (RGNX) market cap is $440.4M on the latest cached fundamentals snapshot.
What kind of company is RGNX?
Regenxbio Inc (RGNX) is a biotechnology company listed on US.
Where is RGNX stock news listed?
Cached stock news for Regenxbio Inc (RGNX) is listed at https://lician.com/news/rgnx. Filings: https://lician.com/sec/rgnx
Not investment advice.